COM:MARKERTHERAPEUTICS
Marker Therapeutics
- Stock
Last Close
3.18
21/11 21:00
Market Cap
44.42M
Beta: -
Volume Today
41.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 7.50K - | -500K - | -500K 0% | 0.50 - | ||||||||
average payables | 1.57M - | 1.04M 33.84% | 794.09K 23.31% | 823.77K 3.74% | 847.59K 2.89% | 1.32M 55.38% | 1.31M 0.84% | 1.96M 50.38% | 4.04M 105.68% | 3.38M 16.38% | 1.68M 50.31% | |
average receivables | 538.50 - | 54.09K - | 82.18K 51.94% | 528.37K 542.92% | 500.40K 5.29% | 1.20M 140.03% | 1.71M 42.78% | |||||
book value per share | -926.16 - | -7.94 99.14% | -58.33 634.32% | 8.98 115.39% | 3.87 56.89% | 31.08 703.22% | 9.67 68.89% | 5.81 39.89% | 5.75 1.10% | 2.35 59.18% | 1.60 32.04% | |
capex per share | -0.08 - | -0.08 6.35% | -2.22 2,595.06% | -0.41 81.54% | -0.59 44.69% | |||||||
capex to depreciation | -1.31 - | -9.69 640.89% | -0.99 89.79% | -1.34 35.71% | ||||||||
capex to operating cash flow | 0.01 - | 0.02 101.10% | 0.55 2,596.08% | 0.11 79.24% | 0.18 59.74% | |||||||
capex to revenue | -0.72 - | -1.76 145.36% | -22.34 1,170.12% | -2.52 88.71% | -0.55 78.22% | |||||||
cash per share | 5.13 - | 1.10 78.54% | 17.96 1,530.44% | 11.40 36.54% | 5.43 52.39% | 32.34 496.07% | 9.63 70.22% | 4.54 52.87% | 5.54 21.95% | 1.41 74.51% | 1.72 21.58% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 191.68 - | 96.20 49.81% | 782.38 713.30% | 0.07 99.99% | 97.37 139,660.52% | 113.30 16.37% | ||||||
debt to assets | 45.20 - | 0.24 99.48% | 0.01 96.62% | 0.00 92.09% | 0.00 52.91% | 0.01 - | 0.27 2,471.80% | 0.17 35.18% | 0.22 27.03% | |||
debt to equity | -0.40 - | -0.05 86.98% | -0.00 95.20% | 0.00 132.58% | 0.00 69.06% | 0.01 - | 0.45 3,979.80% | 0.27 39.80% | 0.39 44.01% | |||
dividend yield | ||||||||||||
earnings yield | -2.44 - | -7.13 192.89% | -1.29 81.89% | -0.09 92.89% | -0.30 222.65% | -1.40 371.18% | -0.15 88.91% | -0.42 170.13% | -0.58 37.75% | -1.33 130.29% | -0.35 73.60% | |
enterprise value | 5.71M - | 4.24M 25.67% | 19.84M 367.90% | 18.89M 4.83% | 31.93M 69.08% | 44.21M 38.46% | 87.87M 98.75% | 59.11M 32.73% | 42.20M 28.61% | 18.38M 56.44% | 33.34M 81.37% | |
enterprise value over ebitda | -2.14 - | -1.26 41.25% | -3.22 156.09% | -2.29 29.03% | -2.67 16.59% | -0.30 88.80% | -3.95 1,222.57% | -2.12 46.21% | -1.16 45.27% | -0.70 39.77% | -2.29 226.71% | |
ev to operating cash flow | -8.21 - | -1.94 76.39% | -4.57 135.61% | -2.90 36.50% | -3.78 30.42% | -3.05 19.30% | -4.81 57.39% | -3.13 34.78% | -1.55 50.65% | -0.68 55.94% | -2.03 197.57% | |
ev to sales | 214.63 - | 412.17 92.04% | 126.64 69.28% | 33.98 73.16% | 2.04 93.99% | 10.07 393.24% | ||||||
free cash flow per share | -73.37 - | -16.97 76.87% | -11.86 30.12% | -9.45 20.33% | -8.93 5.52% | -7.66 14.18% | -4.09 46.58% | -6.23 52.11% | -3.97 36.16% | -3.82 3.85% | -1.87 51.17% | |
free cash flow yield | -0.31 - | -0.51 65.22% | -0.16 67.39% | -0.24 47.84% | -0.23 6.48% | -0.14 39.38% | -0.14 2.95% | -0.43 202.13% | -0.42 2.55% | -1.42 238.31% | -0.34 76.03% | |
graham net net | -929.17 - | -8.58 99.08% | -58.51 581.74% | 8.87 115.17% | 3.82 57.01% | 30.92 710.27% | 9.14 70.43% | 0.71 92.25% | 2.38 235.82% | -0.15 106.23% | 1.45 1,081.12% | |
graham number | 3.49K - | 206.94 94.07% | 349.39 68.83% | 26.83 92.32% | 31.80 18.54% | 232.80 632.01% | 31.15 86.62% | 28.16 9.58% | 26.61 5.52% | 13.75 48.31% | 8.31 39.55% | |
income quality | 0.13 - | 0.07 43.59% | 0.13 80.03% | 2.65 1,979.47% | 0.77 71.02% | 0.10 87.26% | 0.85 771.91% | 0.66 23.01% | 0.65 0.85% | 0.90 38.34% | 1.17 29.88% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -1.88 - | -5.86 210.80% | -563.75 9,525.30% | 1.98K - | ||||||||
interest debt per share | 553.34 - | 4.88 99.12% | 0.17 96.42% | 0.01 95.84% | 0.01 27.12% | 0.11 - | 2.61 2,352.39% | 1.55 40.46% | 0.91 41.32% | |||
inventory turnover | ||||||||||||
invested capital | -0.40 - | -0.05 86.98% | -0.00 95.20% | 0.00 132.58% | 0.00 69.06% | 0.01 - | 0.45 3,979.80% | 0.27 39.80% | 0.39 44.01% | |||
market cap | 2.27M - | 4.33M 90.58% | 26.37M 508.93% | 26.73M 1.38% | 37.06M 38.62% | 105.96M 185.93% | 131.29M 23.91% | 68.21M 48.05% | 72.68M 6.56% | 22.55M 68.98% | 48.45M 114.88% | |
net current asset value | -8.77M - | -1.02M 88.33% | -21.36M 1,986.71% | 6.18M 128.95% | 3.66M 40.85% | 59.19M 1,518.13% | 43.21M 27.00% | 6.14M 85.79% | 21.83M 255.54% | 1.80M 91.76% | 14.05M 681.52% | |
net debt to ebitda | -1.29 - | 0.03 102.05% | 1.06 3,911.69% | 0.95 10.31% | 0.43 54.97% | 0.42 2.57% | 1.95 367.94% | 0.33 83.25% | 0.84 156.95% | 0.16 81.11% | 1.04 553.45% | |
net income per share | -584.40 - | -239.63 59.00% | -93.02 61.18% | -3.56 96.17% | -11.62 225.98% | -77.50 567.10% | -4.46 94.25% | -6.06 36.00% | -5.47 9.75% | -3.58 34.55% | -1.93 46.23% | |
operating cash flow per share | -73.37 - | -16.97 76.87% | -11.86 30.12% | -9.45 20.33% | -8.93 5.52% | -7.58 15.04% | -4.01 47.12% | -4.01 0.04% | -3.57 11.06% | -3.23 9.42% | -1.87 42.22% | |
payables turnover | ||||||||||||
receivables turnover | 1.90 - | 3.79 99.25% | 0.47 87.70% | 5.24K 1,122,946.25% | 3.75 99.93% | 3.22 14.06% | ||||||
research and ddevelopement to revenue | 601.95 - | 59.87 90.05% | 40.45 32.44% | 22.38 44.66% | 2.90 87.03% | 3.15 8.37% | ||||||
return on tangible assets | -71.82 - | -137.60 91.58% | -5.13 96.27% | -0.31 93.95% | -2.12 583.92% | -2.38 12.31% | -0.44 81.58% | -0.63 42.63% | -0.61 1.73% | -0.87 41.41% | -0.99 14.00% | |
revenue per share | 0.11 - | 0.05 56.66% | 0.10 112.19% | 0.16 63.56% | 1.08 564.35% | 0.38 65.14% | ||||||
roe | 0.63 - | 30.17 4,681.35% | 1.59 94.71% | -0.40 124.89% | -3.00 656.17% | -2.49 16.95% | -0.46 81.51% | -1.04 126.26% | -0.95 8.75% | -1.53 60.32% | -1.21 20.88% | |
roic | 0.68 - | 6.50 857.61% | 0.53 91.91% | 2.00 280.65% | -2.99 249.23% | -2.49 16.51% | -0.47 80.98% | -0.55 16.69% | -0.58 5.30% | -0.86 47.42% | -1.04 20.79% | |
sales general and administrative to revenue | 118.35 - | 46.80 60.46% | 22.43 52.06% | 10.41 53.60% | 1.42 86.32% | 2.26 58.58% | ||||||
shareholders equity per share | -926.16 - | -7.94 99.14% | -58.33 634.32% | 8.98 115.39% | 3.87 56.89% | 31.08 703.22% | 9.67 68.89% | 5.81 39.89% | 5.75 1.10% | 2.35 59.18% | 1.60 32.04% | |
stock based compensation to revenue | 79.37 - | 25.13 68.34% | 11.20 55.42% | 4.80 57.12% | 0.59 87.64% | 0.26 56.32% | ||||||
tangible asset value | -8.77M - | -1.02M 88.33% | -21.36M 1,986.71% | 6.18M 128.95% | 3.66M 40.85% | 59.34M 1,522.16% | 44.09M 25.71% | 27.34M 37.97% | 43.99M 60.86% | 19.60M 55.44% | 14.05M 28.31% | |
tangible book value per share | -926.16 - | -7.94 99.14% | -58.33 634.32% | 8.98 115.39% | 3.87 56.89% | 31.08 703.22% | 9.67 68.89% | 5.81 39.89% | 5.75 1.10% | 2.35 59.18% | 1.60 32.04% | |
working capital | -8.77M - | -1.02M 88.33% | -21.36M 1,986.71% | 6.18M 128.95% | 3.66M 40.85% | 59.19M 1,518.13% | 43.49M 26.52% | 18.01M 58.59% | 33.08M 83.69% | 8.84M 73.29% | 14.05M 59.01% |
All numbers in (except ratios and percentages)